Part of a comprehensive analysis of the Human Biomedical Research Act 2015
All Parts in This Series
Appeals Mechanism under the Human Biomedical Research Act 2015: An In-Depth Analysis
The Human Biomedical Research Act 2015 (the Act) establishes a comprehensive regulatory framework governing human biomedical research in Singapore. Part 9 of the Act specifically addresses the appeals process available to persons aggrieved by decisions made by the Director-General under the Act. This article provides a detailed examination of the key provisions in Part 9, their purposes, and the practical implications for stakeholders involved in biomedical research.
Key Provisions and Their Purpose in Part 9: Appeals
Part 9 of the Act sets out a clear and structured mechanism for appeals against decisions, orders, or directions issued by the Director-General. The key provisions are found primarily in sections 54 and 55, which collectively empower aggrieved persons to seek redress and ensure that decisions are subject to review by a higher authority—the Minister.
"Any person who is aggrieved by ... any decision of the Director‑General ... may ... appeal to the Minister in the prescribed manner." — Section 54(1), Human Biomedical Research Act 2015
Verify Section 54 in source document →
This provision establishes the fundamental right of appeal. It ensures that individuals or entities affected by the Director-General’s decisions have a formal avenue to challenge those decisions. The phrase "in the prescribed manner" implies that procedural rules, likely set out in subsidiary legislation or regulations, govern how appeals must be lodged, ensuring consistency and fairness in the process.
"The Minister may determine an appeal ... by confirming, varying or reversing any decision, order or direction of the Director‑General; or by directing the Director‑General to reconsider the Director‑General’s decision, order or direction." — Section 54(7), Human Biomedical Research Act 2015
Verify Section 54 in source document →
This provision confers broad powers on the Minister to resolve appeals. The Minister may uphold the original decision, modify it, overturn it, or require the Director-General to reconsider the matter. This flexibility is crucial to ensure that decisions are just and appropriate, reflecting the complex and sensitive nature of biomedical research governance.
"The Minister may establish an Appeals Advisory Panel ... to provide advice to the Minister with regard to the discharge of the Minister’s functions under section 54 in respect of any appeal." — Section 55(1), Human Biomedical Research Act 2015
Verify Section 55 in source document →
The establishment of an Appeals Advisory Panel serves an important advisory function. Given the technical and ethical complexities inherent in biomedical research, the Minister may require expert guidance before making a final determination. This panel ensures that appeals involving intricate scientific or ethical issues are informed by specialized knowledge, enhancing the quality and legitimacy of the Minister’s decisions.
"The decision of the Minister in any appeal is final." — Section 54(9), Human Biomedical Research Act 2015
Verify Section 54 in source document →
This clause provides finality and certainty to the appeals process. By making the Minister’s decision conclusive, the Act prevents protracted litigation or repeated challenges, which could delay research activities or regulatory enforcement. It balances the need for review with the importance of administrative efficiency and regulatory certainty.
Purpose of These Provisions:
- Access to Justice: The right to appeal ensures that persons affected by regulatory decisions have a fair opportunity to contest them, promoting transparency and accountability.
- Checks and Balances: By allowing the Minister to review and alter decisions, the Act introduces a system of oversight over the Director-General’s powers, preventing potential misuse or error.
- Expertise in Decision-Making: The Appeals Advisory Panel provides specialist advice, ensuring that decisions on appeals are well-informed by scientific and ethical considerations.
- Finality and Efficiency: The finality of the Minister’s decision avoids endless appeals, thereby maintaining regulatory stability and enabling timely progress in biomedical research.
Absence of Definitions in Part 9
Unlike other parts of the Act, Part 9 does not contain any explicit definitions or defined terms. This absence indicates that the terms used in the appeals provisions are to be understood in their ordinary meaning or as defined elsewhere in the Act. The lack of definitions simplifies the appeals provisions, focusing on procedural rights rather than substantive terminology.
"No definitions section or defined terms are stated in Part 9." — Human Biomedical Research Act 2015
Verify source in source document →
The purpose of this omission is likely to avoid redundancy and maintain clarity. Since the appeals process is procedural, it relies on terms already established in the Act or common legal parlance, thereby streamlining the legislative text.
Penalties for Non-Compliance: None Specified in Part 9
Part 9 does not prescribe any penalties or offences related to the appeals process. This is consistent with the nature of the provisions, which are procedural rather than substantive or punitive.
"No mention of penalties or offences in Part 9." — Human Biomedical Research Act 2015
Verify source in source document →
The absence of penalties underscores that the appeals process is designed to facilitate review and correction of decisions rather than to punish non-compliance. Penalties for breaches of the Act’s substantive provisions are addressed elsewhere, ensuring that the appeals mechanism remains focused on dispute resolution.
Cross-References to Other Acts: None in Part 9
Part 9 does not contain any cross-references to other legislation. This indicates that the appeals process under the Human Biomedical Research Act is self-contained and does not rely on or invoke provisions from other statutes.
"No references to other Acts appear in Part 9." — Human Biomedical Research Act 2015
Verify source in source document →
This self-containment ensures that appeals are handled within the specific regulatory framework of the Act, providing clarity and avoiding jurisdictional confusion. It also reflects the specialized nature of biomedical research regulation, which requires dedicated procedures tailored to its unique context.
Conclusion
The appeals provisions in Part 9 of the Human Biomedical Research Act 2015 establish a robust and fair mechanism for persons aggrieved by decisions of the Director-General to seek review. By empowering the Minister to confirm, vary, reverse, or order reconsideration of decisions, and by enabling the formation of an expert Appeals Advisory Panel, the Act balances the need for regulatory oversight with the complexities of biomedical research governance. The finality of the Minister’s decision ensures administrative efficiency, while the absence of penalties and cross-references maintains the procedural focus and self-contained nature of the appeals process.
Sections Covered in This Analysis
- Section 54(1) – Right to Appeal
- Section 54(7) – Minister’s Powers on Appeal
- Section 54(9) – Finality of Minister’s Decision
- Section 55(1) – Establishment of Appeals Advisory Panel
Source Documents
For the authoritative text, consult SSO.